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A
Aborigines, Australian, renal disease in (abst) 1318
Acetate blood level changes with HD (abst) 953
Acid-base balance
AE1 and H-ATPase in acidosis/alkalosis 125
cerebral edema, after treatment of DKA 1237
maintenance HD and (abst) 953
transporters, ischemic-reperfusion injury 1106
Acidosis. See also Metabolic acidosis
distal renal tubular, absence of H-ATPase (abst) 948
uremic/non-uremic, GH, IGF-1 58:S-102
Activin-like receptor kinase-5, TGF-pl, developing
metanephros (abst) 1310
Acute renal failure (ARF)
acute pyelonephritis, clinical characteristics (abst) 966
arsine gas exposure, CVVHD (abst) 1317
due to building collapse (abst) 966
ischemic, leukocytes, cell adhesion molecules and 1463
myoglobin cytotoxicity 728
myoglobinuric, pathogenesis of 1956
renal cell injury, nature of 1341
Adhesion molecules
attenuation of ischemic ARF 1463
expression in Shwartzmari reaction, rabbit (abst) 949
in glomerular mesangium 1447
integrin cytoplasmic domain modulates cell
proliferation 1434
integrin-ligand interactions 1454
integrins, laminins in tissue remodeling 1441
integrins and tumor therapy 1413
receptors, role in nephritis 1469
receptors in development and remodeling 1427
rejection of renal allografts 1476
selectin ligands, leukocytes and Fuc-TVII 1418
Adrenal tumor, hypokalemia, hypertension, dissecting
aneurysm (abst) 945
Adult respiratory distress syndrome, arsine gas exposure,
CVVHD (abst) 1317
Advanced glycation end-products (AGEs)
2-m interaction, dialysis-related amyloidosis 1514
binding, AGE receptor in diabetic rat kidney (abst) . . . 1314
imidazolone modifies amyloid /32m 187
oxidative stress, ESRD 1170
pentosidine clearance in RRT 880
Advanced glycosylation end-products (AGEs)
pathogenic role in diabetic nephropathy (abst) 947
pathophysiologic role in CAPD 182
AE1 regulation and H-ATPase in acidosis/alkalosis 125
African Americans
linkage analysis of cytokines in ESRD 819
Study of Kidney Disease (AASK) Trial 244
Age. See also Children
CAPD outcome comparison, older/younger patients
(abst) 957
prerenal azotemia in elderly (abst) 965
renal function in elderly 1196
Albumin
glycated, modulates NO production 27
high glomerular permeability of bikunin 1053
infusion, serum Lp(a) concentration, CAPD (abst) 958
serum, as CAPD morbidity/mortality predictor (abst).. . 959
serum, urea reduction ratios, HD patients (abst) 1326
Albuminuria, low birth weight, RF in Australian
Aborigines (abst) 1318
Alkalosis, metabolic, AE1 regulation and H-ATPase in.. 125
Allografts. See also Rejection
early protocol biopsy, graft outcome and 310
early routine biopsies, histopathology in (abst) 962
intrarenal gene expression during rejection 58:S-15
Allopurinol, ischemia-reperfusion injury, rats (abst) 966
a-subunit of neutrophil NADPH oxidase, in kidney and
liver 479
a1-adrenergic receptor, mRNA expression, rat nephron . 1548
Alport syndrome
bull terrier hereditary nephritis as model (abst) 1320
COL4A5 mutation screening method (abst) 1324
gene therapy 1493
pathobiology, genetics of 58:S-69
transplantation prognosis (abst) 961
Amadori adducts of glycated albumin and NOS activity.... 27
Amino acids
plasma concentrations, ESRD, Koreans and
Americans compared (abst) 954
uremic muscle metabolism 1182
Amylin renal binding correlated with BP, rat (abst) 1309
Amyloidosis
dialysis-related, 2-m binding to collagen-AGE 1514
dialysis-related, 2-m histological prevalence in 1928
dialysis-related, imidazolone modifies j32m 187
Andreoli, Thomas E 1663
Anemia
EPO therapy, in CRF 622
glomerular dysfunction in sickle cell 826
rHuEPO effect 5/6 nephrectomized rat (abst) 945
Anesthesia, surgery, and nitric oxide 1943
Aneurysm, dissecting, hypokalemia, hypertension with
adrenal tumor (abst) 945
Angiotensin-converting enzyme (ACE)
chronic diuresis and renal tubular cells 36
gene polymorphism, cardiac changes post-transplant. . . 1205
gene polymorphism, childhood reflux nephropathy
(abst) 950
gene polymorphism in NIDDM nephropathy (abst) . .. . 946
genotypes and diabetic hyperfiltration 119
inhibitors, aspirin, dipyridamol therapy in IgAN (abst). . 969
Angiotensin II (Ang II)
alters [Ca]i in MC of diabetic rats 87
induces PAT-i in MC 664
intraluminal, RPP, acute volume expansion 44
L-arginine in tissue fibrosis 1481
PAl-i modulation, endothelial injury 164
synthesis/metabolism changes with Na loading (abst) . . 1309
TGF-131, post-subtotal nephrectomy 1553
Anion exchanger AE1 regulation and H-ATPase in
acidosis/alkalosis 125
Antenatal hydronephrosis due to UPJ obstruction (abst) .. 951
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Anti-angiogenic TNP-470 inhibits MC proliferation 1838
Anti-glomerular basement membrane nephritis
anti-IFNy inhibits crescent formation and cutaneous
DTH (abst) 1319
IL-b treatment in rats 1809
macrophage migration inhibitory factor (abst) 1313
susceptibility to, HLA-DRB1 genes and 222
Anti-interferony antibody inhibits cutaneous DTH,
crescent formation in anti-GBM UN (abst) 1319
Anti-platelet antibodies, heparin-induced
thrombocytopenia (abst) 952
Anti-Thy-i antibodies, induce apoptosis of rat MC 173
Anti-Thy-I nephritis, TGF-/31 and PDGF /3 in mice
(abst) 967
Anti-thymocyte antibody-induced UN, MCP-1,
monocyte/macrophage influx 770
Antibiotics, catheter-related sepsis without catheter
removal (abst) 945
Antibodies
agonistic anti-Fas, glomerular apoptosis 1739
anti-IFNy inhibits crescent formation and cutaneous
DTH (abst) 1319
antibody independent crescentic UN 672
dimeric monoclonal IgA anti-Thy-i, apoptosis of MC.. . 173
GN, crescent formation in p. chain deficient mice
(abst) 1319
porcine xenoantigen Gala(i,3) Gal eliminated (abst) . . 1324
porcine xenoantigen Gala(i,3) Gal in transgenic mice
(abst) 1323
Anticardiolipin antibody (ACA), lupus anticoagulant in
vascular access occlusion (abst) 952
Anticoagulation. See Heparin
Antidiuretic hormones, VP and oxytocin function as
(abst) 949
Antigens
HLA system, antigen processing and presentation.... 58:S-2
porcine xenoantigen Gak(i,3) Gal eliminated (abst) . . 1324
porcine xenoantigen Galn(i,3) Gal in transgenic mice
(abst) 1323
Antihypertensive therapy
diet and diabetes 58:S-66
ECM, mononuclear cells in UNX SHR 750
short-term, GFR and stability of renal function 793
Antioxidants
dietary, inhibits lipoprotein oxidation in FSGS 1151
vitamins and EPO production 497
Apical Na-H exchange, IGF-1, human PTC (abst) 1323
Apoptosis
acute rejection, clinicopathology (abst) 962
agonistic anti-Fas antibodies induce glomerular 1739
B-cell selection, in the germinal center (abst) 1321
developing renal corpuscles, prenatal rat kidney (abst) . . 967
Fas, ICE and autoimmunity, CrmA transgenic and lpr
mice (abst) 1321
induced in rat GMC by anti-Thy-i antibodies 173
ionizing radiation, cytotoxic drugs induce in MC (abst). . 968
mesothelial cells, PD solution induces 1280
pyelonephritis provokes, in infant rat renal cortex 1855
TIN, resolution of experimental (abst) 1312
tubulointerstitial nephritis (abst) 964
verapamil effect in CsA nephrotoxicity (abst) 968
Arg-Gly-Asp (RGD peptides) as therapeutics in acute
renal injury 1487
Arsine gas exposure, management with CVVHD (abst) . . 1317
Arterial hypertension, renal consequences of,
Nephrology Forum 1639
Arteriosclerosis in CRF 1678
Arteriovenous fistula (AVF)
closure, anaerobic threshold, cardiac output (abst) . . . . 1321
Thoratec 1327
As4.1 cell line and prorenin activation 104
Aspirin, dipyridamol, ACEi therapy in IgA nephropathy
(abst) 969
Atherosclerosis
in chronic renal failure 1678
CV disease, lipoprotein(a), CAPD (abst) 958
Atkins, Robert C 2037
Atrial natriuretic peptide (ANP)
acute/chronic volume expansion, natriuresis (abst) . . . . 1307
mRNA in diabetic rat kidney 1100
physiologic role and diuretic efficacy 59:S-28
receptors in human CCD cell line 281
Australian Aborigines, renal disease in (abst) 1318
Autoimmunity
Fas and ICE in CrmA transgenic and lpr mice (abst) . . 1321
genetic susceptibility to anti-GBM disease 222
IL-12 in tubular epithelium of MRL-Fas" mice 79
lupus, mycophenolate mofetil limits renal damage 1583
Autosomal dominant polycystic kidney disease (ADPKD)
complications of, Nephrology Forum 353
extrarenal manifestations, Nephrology Forum 2022
sex hormones and fluid secretion in MDCK cells 1535
Axial skeletal BMD changes, post-parathyroidectomy
(abst) 1308
Azathioprine, CsA and lipid peroxidation 1608
Azotemia
in PKD rats 1160
prerenal, clinical characteristics in elderly (abst) 965
B
B-cell selection and apoptosis in the germinal center
(abst) 1321
Baker's yeast (Saccharomyces cerevisiae), hypoxia in 507
Basal serum biochemical markers of survival, HD (abst) . . 956
Benign familial hematuria, thin GBM nephropathy 1596
/32-microglobulin (/32-m)
amyloid, histological prevalence in HD 1928
amyloid, modified with imidazolone, dialysis 187
binding to collagen-AGE in DRA 1514
Bicarbonate
concurrent salbutamol, acute therapy of hyperkalemia
(abst) 957
muscle mass in metabolic acidosis (abst) 948
Bikunin, high glomerular permeability 1053
Bioelectrical impedance, LBM derived from, in ESRD,
HD (abst) 955
Bioimpedance spectroscopy, postural changes, volume
estimation 1078
Biopsy, renal
11J3HSG2 findings in renal disease (abst) 1310
absence of H-ATPase in distal renal tubular acidosis
(abst) 948
allograft histopathology in recipients (abst) 962
early protocol allograft, graft outcome and 310
expression of multiple cytokines, human (abst) 1311
manual and automated, comparative study (abst) 968
percutaneous, complications after 969
Biopty gun, percutaneous kidney biopsy (abst) 1316
Biostat urea monitor
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evaluates solute clearance, dialysis adequacy (abst). . . . 1330
evaluation of (abst) 1329
Blood lipids and PAl-i in CsA nephropathy 1818
Blood pressure
Ang II and L-arginine in tissue fibrosis 1481
central response to ROS, CRF (abst) 954
hypoalbuminemia, HD 1212
low Ca dialysate, Ca metabolism, CAPD (abst) 1328
nycthemeral pattern in treated hypertension, HD 1863
Blood transfusion during heparin-free HD 2018
Bone disease
Ca handling in ovariectomized rat 1719
Ca stone risk factors, post-transplant 804
fractures, vitamin K and iPTH 1218
parathyroid Ca sensing 1590
predialysis patients in Korea (abst) 956
site specific risk factors, dialysis (abst) 1329
steroid-induced, frequently relapsing childhood
MCNS, la(OH)-vitamin D3 (abst) 965
Bone mineral density (BMD)
axial skeletal changes, post-parathyroidectomy (abst) . . 1308
i.v. calcitriol effect, SHPTH, chronic HD (abst) 955
pitfalls of DXA in dialysis (abst) 1329
Brain
edema, pathogenesis and therapy 59:S-69
intrinsic erythropoietin production 416
oxygen pressure in 372
Brain natriuretic peptide (BNP)
ouabain, effects in saline-loaded sheep (abst) 1308
release, body fluid balance (abst) 950
Breast cancer, postmastectomy edema 59:S-76
Brush border membrane (BBM) vesicles, cadmium effect
on Na-Pi transport, rabbits (abst) 949
Bull terrier hereditary nephritis as model for Alport
syndrome (abst) 1320
C
C-type natriuretic peptide (CNP) receptors in human
CCD cell line 281
C3
activated, and IgA nephropathy 1257
gene expression, TNF-a regulates in endothelial cells. . . 703
receptors, cultured rat glomerular endothelial cells. . . . 1124
C6, extrahepatic/hepatic, generation of renal C5b-9 1788
CA125 in peritoneal effluent 888
Cadmium effect in Na-Pi transport, rabbit BBM vesicles
(abst) 949
Calciphylaxis in renal failure (abst) 1315
Calcitonin effect on calcium transport 1999
Calcitriol
i.v. effect on SHPTH and BMD, chronic HD (abst) .... 955
tubular Ca reabsorption in CRF (abst) 1308
Calcium
-induced mitochondrial swelling by CsA (abst) 964
cytosolic, Ang II and norepinephrine, MC of diabetic
rats 87
cytosolic, hypoxia and tyrosine hydroxylase gene
expression 536
handling in ovariectomized rat 1719
intracellular, myoglobin cytotoxicity in PT cells 728
intracellular, PTC elevation, PTH-PTHrP, Via, AT1
receptors in diabetes 1950
metabolism, low Ca dialysate, BP, CAPD (abst) 1328
pump inhibitors in uremic plasma 1042
reabsorption, defective in genetic hypercalciuric rats. . . 1540
reabsorption in CRF, calcitriol (abst) 1308
receptor, parathyroid expression in
hyperparathyroidism 328
salt urolithiasis, thermodynamic equilibrium model
(abst) 1315
sensing in renal osteodystrophy, PTH and 1590
transport, calcitonin effect on 1999
urinary excretion, children with UTI (abst) 967
Calcium channel blockers
skeletal muscle metabolism (abst) 1306
verapamil, apoptosis in CsA nephrotoxicity (abst) 968
verapamil, morphology and CsA nephrotoxicity (abst) . . 965
Calcium oxalate
monohydrate crystals, renal cell OPN release 679
urinary supersaturation, post-transplant 804
Calculi
Ca salt urolithiasis, thermodynamic equilibrium model
(abst) 1315
Ca stone risk factors, post-transplant 804
crystal inhibition in rats 640
defective calcium reabsorption 1540
supersaturation and stone composition 894
Cameron, J. Stewart 2060
Cancer
postmastectomy edema 59:S-76
thyroid, overlap type of polyarteritis nodosa (abst) 946
tumor markers in CRF (abst) 954
Carbachol, renal Na-HCO3 cotransporter 1069
Carbohydrate metabolism, role of oxygen in zonation of . . 402
Cardiovascular disease
atherosclerosis and arteriosclerosis in CRF 1678
atherosclerotic, Lp(a), CAPD (abst) 958
BP variability in ESRD 1863
heart failure, diuretic-resistant edema in 59:S-66
heart failure, hemofiltration in severe 59:S-62
heart failure, water and Na retention in 59:S-57
hypercholesterolemia and transplantation (abst) 1322
LVH post-transplant 1205
screening elderly transplant recipients for (abst) 1322
Cardiovascular function
As4.1 cell line and prorenin activation 104
cardiac output and AVF closure (abst) 1321
renal function in the elderly 1196
Carnitine deficiency, skeletal muscle metabolism, CRF
(abst) 1309
Catheters. See Vascular access
CD8 T-cell depletion, proteinuria, Heymann nephritis
(abst) 1325
CD28:B7 costimulatory interaction, alloimmune
responses 58:S-8
CD4O-induced chemokine production by hPTEC 711
Cell death in hypoxia and tyrosine phosphorylation 1747
Cell proliferation modulated by integrin cytoplasmic
domain 1434
Cellular immunity, determinants of susceptibility to ON. . . 646
Central neurons, sensing oxygen deprivation in 467
Cerebral edema after treatment of DKA 1237
Chemokines
anti-Thy antibody-induced ON, MCP-1 770
CD4O-induced production by hPTEC 711
MCP-1 pathogenesis in cryoglobulinemic GN 153
regulation by IL-6-like cytokines 1754
renal disease and 610
Chemotherapeutic cisplatin, reversible multiorgan failure
with (abst) 948
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Children. See also North American Pediatric Renal
Transplant Cooperative Study
ACE gene polymorphism in reflux nephropathy (abst) . . 950
born to transplant recipient mothers (abst) 1322
CVVH and CVVHD in critically ill (abst) 1326
edema in 59:S-100
enhanced LDL uptake, nephrosis (abst) 1313
frequently relapsing MCNS, 1 a(OH)-vitamin D3,
osteoporosis (abst) 965
growth factors in CRF 1970
LH receptor inhibitors in boys with CRF 777
long-term rhGH in CR! 58:S-114
membranous GN, clinical studies (abst) 970
PermCath HD access catheters (abst) 952
renal outcome one-year after UT! (abst) 1305
TGBM disease without glomerular IgA deposits (abst).. 969
UT!, Australian Aborigines (abst) 1318
VUR therapy prevents ESRD from reflux nephropathy
(abst) 1306
Chinese medicine, NEP monitors PT injury, herbal
nephropathy 288
Chloride channel blockers, cytoprotective effects in
hypoxia 1529
Chloride channels, volume regulation and 477
Chlorothiazide alters Mg2 transport in DCT 1008
Cholesterol, blood lipids and PAl-i in CsA
nephrotoxicity 1818
Cholinergics, carbachol and renal Na-HCO3
cotransporter 1069
Chronic renal failure (CRF)
atherosclerosis and arteriosclerosis in 1678
central pressor response to ROS (abst) 954
diuretic therapy in 59:S-33
EPO therapy of anemia in 622
extended IGF-1 use 840
GH/IGF axis, derangements in 58:S-106
growth factors in children 1970
immature reticulocytes indicate erythropoiesis (abst) . . . 953
isolated C3 mesangial proliferative GN (abst) 946
LH receptor inhibitors in boys 777
NS pathologic types, protein C and S (abst) 965
renal nerves and hypertension 722
skeletal muscle metabolism, propionyl L-caritine (abst). 1309
tubular Ca reabsorption, calcitriol (abst) 1308
tumor markers in (abst) 954
Chronic renal insufficiency (CR1), long-term rhGH in
children 58:S-114
Ciprofloxacin, gentamicin, compared in acute
pyelonephritis (abst) 1316
Cirrhosis, water and Na retention in 59:S-43
Cisplatin-based chemotherapy, reversible multiorgan
failure with (abst) 948
Cobalt chloride
oxygen sensing pathways in HepG2 cells 483
ROS and EPO production 492
COL4A5 mutation screening method, Alport syndrome
(abst) 1324
Collagen III myofibroblast and a1(I!I) expression in TIN. . 926
Collagen IV synthesis and endothelial cell proliferation
(abst) 964
Complement
activated C3 and IgAN 1257
C3 receptors, cultured rat glomerular endothelial cells . 1124
extrahepatic C6 and renal C5b-9 1788
synthesis by endothelial cells 703
Congenital nephrotic syndrome, Finnish type, DNA-
based diagnosis 868
Connective tissue, PDGF as regulator in embryogenesis,
pathogenesis 1361
Continuous ambulatory peritoneal dialysis (CAPD)
AGE peritoneal accumulation/detection 182
albumin infusion, serum Lp(a) concentration (abst) . . . . 958
atherosclerotic CV disease, Lp(a) (abst) 958
clinical outcome predictors (abst) 959
connector systems compared, peritonitis and (abst) 960
disconnect/discard system assessment (abst) 1327
exit-site infection, surgical management (abst) 960
fluid transfer systems compared (abst) 1329
fusidic acid concentrations in dialysate (abst) 1328
gastric emptying time (abst) 957
human peritoneal fibroblast in 3D culture 205
IGF-1 and nutritional status (abst) 960
laparoscopic Tenckhoff catheter insertion (abst) 1328
lean body mass measurements compared (abst) 959
low Ca dialysate, Ca metabolism, BP (abst) 1328
nitroprusside and peritoneal permeability 1885
outcome comparison, older/younger patients (abst) 957
peritoneal membrane transport, nutritional status
(abst) 958
risk factors for hypercalcemia (abst) 959
serum albumin as morbidity/mortality predictor (abst) . . 959
serum Lp(a), apolipoprotein(A) (abst) 958
surgical aspects of PD (CAPD) access (abst) 1328
Continuous veno-veno hemodialysis (CVVHD)
arsine gas exposure, ARF (abst) 1317
in critically ill children (abst) 1326
Continuous veno-venous hemofiltration (CVVH) in
critically ill children (abst) 1326
Contrast media effects in acute ureteral obstruction 653
Cortical collecting ducts (CCD)
natriuretic peptide receptors in human cell line 281
sodium nitroprusside, effects in rats 473
Creatinine
clearance, as index of nutritional status (abst) 954
fingernail concentration, as RF marker (abst) 1317
generation rate and LBM, in PD 855
serum, ESRD prognostic significance 850
Crescent formation, anti-IFNy inhibits cutaneous DTH,
anti-GBM GN (abst) 1319
Crescentic glomerulonephritis
antibody independent 672
fibrin dependent, T-cells, tissue factor pathway
inhibitor (abst) 1320
IL-b treatment in rats 1809
SK&F105685 suppresses cutaneous DTH, rats (abst) . . 1325
Thi cells direct crescent formation, mice 94
tissue factor inhibition, renal injury, fibrin deposits
(abst) 1310
tissue factor pathway inhibitor, fibrin deposits (abst). . . 1313
TNF-c, IL-i blocking, rats (abst) 1325
Crush syndrome, ARF due to (abst) 966
Cryoglobulinemic membranoproliferative GN,
pathogenetic role of MCP-1 153
Cyclic adenosine monophosphate (cAMP)
-responsive HIF-1 DNA recognition site 564
hepatorenal link, proximal reabsorption, renal
hemodynamics 59:S-50
Cyclic ADP-ribose metabolism in glomeruli 1500
Cyclin kinase inhibitor determines MC proliferation 1088
Cyclins
Subject Index: Vol. 51 2101
E-cdk 2 activation, MC cycle control by TGF-f31 1228
expression during renal development 762
Cyclophosphamide therapy, lupus nephritis, renal
survival in black Americans 1188
Cyclosporine (CsA)
-induced remission of relapsing MCNS (abst) 946
cellular proliferation during compensatory renal
growth (abst) 965
lipid peroxidation, post-transplant 1608
steroid-resistant idiopathic NS 58:S-85
Cyclosporine (C5A) nephrotoxicity
blood lipids and PAT-i in 1818
inhibition of Ca-induced mitochondrial swelling in
kidney (abst) 964
verapamil, morphologic effect of (abst) 965
verapamil effect on apoptosis (abst) 968
Cystinuria and SLC3A1 mutation 1893
Cytochrome b58 and oxygen sensing 479
Cytochrome P450-derived renal HETEs 1696
Cytokines
action, importance of context in 1352
biology of TGF-f3, knockout and transgenic mouse
models 1355
expression of multiple, human renal biopsies (abst). . . . 1311
gelatinase A and MC growth 1397
human peritoneal fibroblast in 3D culture 205
IL-6, LIF, oncostatin, regulate chemokines 1754
immune injury, TGF-J3 and endothelial cells 1401
immunosuppressive drug comparisons on mRNA
profiles, human MLC (abst) 1320
linkage analysis and ESRD 819
macrophage migration inhibitory factor, anti-GBM ON
(abst) 1313
PDGF and connective tissue 1361
regulate LTB4 synthesis in monocytes 1520
regulation of vascular morphogenesis by SPARC 1383
schistosome-induced granuloma and fibrosis 1370
TGF-13, activation of latent 1376
TGF-13 in kidney fibrosis, gene therapy target 1388
Cytomegalovirus (CMV)
detection in transplant recipients (abst) 961
gancyclovir, optimal indication of treatment (abst) 961
Cytotoxicity
drugs, ionizing radiation induce MC apoptosis (abst) . . . 968
in glomeruli, T-cells in Heymann nephritis 1059
myoglobin, in PT cells 728
pyruvate dialysate and PD toxicity 860
D
Decorin expression in hydronephrosis 1133
Delayed-type hypersensitivity
antibody independent GN, crescent formation in jx
chain deficient mice (abst) 1319
cutaneous, anti-IFNy inhibits crescent formation, anti-
GBMGN(abst) 1319
cutaneous, crescentic ON, suppressed by SK&F105685,
rats (abst)
Denys-Drash syndrome, WT1 gene mutation, molecular
genetic study (abst)
Desferrioxamine
oxygen sensing pathways in HepG2 cells 483
ROS and EPO production 492
Diabetes
ANP mRNA in rat kidneys 1100
[Ca2j, PTH, Vla, AT1 receptors in 1950
mesangial cell actin disassembly 1797
Diabetes mellitus (DM)
intrarenal IGF-1, regional changes in 811
oxidant stress in kidney (abst) 1314
post-transplant (abst) 963
type II, hereditary factors in 1602
type II, intrarenal vascular resistance 1920
Diabetic ketoacidosis, cerebral edema after treatment of . 1237
Diabetic nephropathy (DN)
ACE gene polymorphism, renal hemodynamics 119
ACE gene polymorphism in NIDDM (abst) 946
AGE binding, quantitation and receptor, rat kidney
(abst) 1314
AGE pathogenic role (abst) 947
AGE pathophysiologic role in CAPD 182
[Cali, Ang II, norepinephrine in rat MC 87
elevated plasma total renin precedes microalbuminuria
(abst) 1309
glycated albumin modulates NO production 27
hereditary factors in type II diabetes 1602
intrarenal hemodynamic abnormalities measured 1920
lipoprotein metabolism, antioxidants, IDDM (abst). . . . 1305
morphometric analysis of mesangium 1624
MRI and kidney morphology 50
myofibroblasts correlate with fibrotic markers (abst). . . 1314
pathogenesis, glomerular mechanical strain in 57
perindopril, enalapril compared (abst) 1309
progression, glucose control and (abst) 947
proteinuric progressive, renal ET 58:S-66
"What doctors don't know about kidneys," by Senator
Jake Garn 1340
Dialysate
dialyzer urea mass transfer-area coefficients 2013
low Ca, BP, Ca metabolism in CAPD (abst) 1328
PD, induces mesothelial cell apoptosis 1280
PD solutions with thiol compounds, glucose
degradation (abst) 1330
pyruvate, PD toxicity and 860
Dialysis
chronic HD, dryness, and fluid overload 59:S-39
diet and metabolic acidosis (abst) 955
HCV infection 981
increased reticulated platelets 834
osteopenia, site specific risk factors (abst) 1329
peracetic acid dialyzer re-use program (abst) 1330
post-dialysis urea concentration, estimation of
equilibrated 2000
Dialyzer urea mass transfer-area coefficients 2013
Diet
antihypertensives and diabetes 58:S-66
antioxidants inhibit lipoprotein oxidation in FSGS .... 1151
low protein, metabolism in uremia 1222
metabolic acidosis in chronic dialysis (abst) 955
Modification of Diet in Renal Disease Study Group. . . 1908
Dioxin-regulated gene expression, mouse hepatoma cells. . 567
Dipyridamol, aspirin, ACEi therapy in IgA nephropathy
1325 (abst) 969
Distal convoluted tubule cells
949 phosphate depletion and Mg2 uptake in mouse DCT. 1710
thiazides alter Mg2 transport 1008
Distal renal tubular acidosis, absence of H -ATPase on
biopsy (abst) 948
Diuretics
-resistant edema in heart failure 59:S-66
adverse reactions of 59:S-16
2102 Subject Index: VoL 51
loop, ACE, chronic diuresis and renal tubular cells 36
mechanism of action, renal transport and 59:S-1 I
thiazides alter Mg2 transport in DCT 1008
thiazides correct SHR hypercalciuria 1018
use in chronic renal failure 59:S-33
use in hypertensives 59:S-36
DMSA renal scan, acute pyelonephritis, adults (abst). . . . 1319
DNA
-based diagnosis, congenital NS, Finnish type 868
damage, tyrosine phosphorylation in hypoxia 1747
HIF-1 recognition site is cAMP responsive 564
library screening, changing patterns of gene expression. . 920
representational difference analysis, gene eDNA in
embryonic kidney 1629
DOCA-salt hypertensive rats, isolated kidney function
(abst) 1307
Donor kidneys
age/sex and graft survival rates (abst) 962
cadaveric, donor factors, early graft function (abst) 961
living related, flow cytometry crossmatch (abst) 961
Doppler sonography
duplex, measures intrarenal hemodynamic
abnormalities in DN 1920
evaluates percutaneous renal biopsy complications
(abst) 969
Dual energy x-ray ahsorptiometiy (DXA) pitfalls in
dialysis (abst) 1329
E
Early growth response gene-i (Egr-l), MC proliferation . . 694
Early protocol renal allograft biopsies 310
Ecto-5'-nucleotidase in kidney and liver 479
Edema
ANP effects in healthy and renal subjects 59:S-28
in the brain, pathogenesis and therapy 59:S-69
in childhood 59:S-100
chronic arm, after breast cancer therapy 59:S-76
dialysis, dryness, and fluid overload 59:S-39
diuretic-resistant, in heart failure 59:S-66
diuretic therapy in CRF 59:S-33
diuretic therapy in hypertensives 59:S-36
diuretics, adverse reactions of 59:S-16
diuretics and renal transport 59:S-11
formation, the problem of 59:S-1
hemofiltration in severe heart failure 59:S-62
history of, and its management 59:S-118
history of common salt 59:S-127
in the ICU, causes of 59:S-105
myxedema and hypothyroidism 59:S-82
neonatal 59:S-97
in nephrotic syndrome 9:S-2i
in nephrotic syndrome, intractable 58:S-75
overview of edematous states 59:S-2
pathogenesis of formation in NS 58:S-72
plants as sources of salt 59:S-114
plasma cAMP and renal function 59:S-50
in pregnancy 59:S-90
unusual disorder of salt and water balance 59:S-11 I
VP and oxytocin as antidiuretic hormones (ahst) 949
water and Na retention in cirrhosis 59:S-43
water and Na retention in heart failure 59:S-57
Elderly
CAPD outcome comparison, older/younger patients
(abst) 957
prerenal azotemia, clinical characteristics (abst) 965
renal function in 1196
11 /3-hydroxysteroid dehydrogenase type II, biopsy
findings in renal disease (abst) 1310
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